MiR-30a-5p/CHD1 axis enhances cisplatin sensitivity of ovarian cancer cells via inactivating the Wnt/β-catenin pathway : Anti-Cancer Drugs

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Original Studies

MiR-30a-5p/CHD1 axis enhances cisplatin sensitivity of ovarian cancer cells via inactivating the Wnt/β-catenin pathway

Wang, Xiaoyana,*; Zhao, Hongb,*; Wang, Peia; Zhang, Jinbina; Li, Naa; Liu, Yangyangc; Zhang, Fengc; Yu, Yanlingd

Author Information
doi: 10.1097/CAD.0000000000001397
  • Buy

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.